258 related articles for article (PubMed ID: 18703014)
21. Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.
Wray CJ; Sun X; Gang GI; Hasselgren PO
J Surg Res; 2002 May; 104(2):82-7. PubMed ID: 12020124
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-methylbutyrate.
Smith HJ; Wyke SM; Tisdale MJ
Cancer Res; 2004 Dec; 64(23):8731-5. PubMed ID: 15574784
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of skeletal muscle atrophy in cancer cachexia by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):517-27. PubMed ID: 19112551
[TBL] [Abstract][Full Text] [Related]
24. Cellular mechanisms controlling protein degradation in catabolic states.
Ding X; Price SR; Bailey JL; Mitch WE
Miner Electrolyte Metab; 1997; 23(3-6):194-7. PubMed ID: 9387115
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
26. Branched-chain amino acids: a role in skeletal muscle proteolysis in catabolic states?
Busquets S; Alvarez B; López-Soriano FJ; Argilés JM
J Cell Physiol; 2002 Jun; 191(3):283-9. PubMed ID: 12012323
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of induction of muscle protein loss by hyperglycaemia.
Russell ST; Rajani S; Dhadda RS; Tisdale MJ
Exp Cell Res; 2009 Jan; 315(1):16-25. PubMed ID: 18973755
[TBL] [Abstract][Full Text] [Related]
28. Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis.
Klaude M; Mori M; Tjäder I; Gustafsson T; Wernerman J; Rooyackers O
Clin Sci (Lond); 2012 Feb; 122(3):133-42. PubMed ID: 21880013
[TBL] [Abstract][Full Text] [Related]
29. Ca(2+)-dependent proteolysis in muscle wasting.
Costelli P; Reffo P; Penna F; Autelli R; Bonelli G; Baccino FM
Int J Biochem Cell Biol; 2005 Oct; 37(10):2134-46. PubMed ID: 15893952
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoids regulate mRNA levels for subunits of the 19 S regulatory complex of the 26 S proteasome in fast-twitch skeletal muscles.
Combaret L; Taillandier D; Dardevet D; Béchet D; Rallière C; Claustre A; Grizard J; Attaix D
Biochem J; 2004 Feb; 378(Pt 1):239-46. PubMed ID: 14636157
[TBL] [Abstract][Full Text] [Related]
31. An assay of microsomal membrane-associated proteasomes demonstrates increased proteolytic activity in skeletal muscle of intensive care unit patients.
Klaude M; Hammarqvist F; Wemerman J
Clin Nutr; 2005 Apr; 24(2):259-65. PubMed ID: 15784487
[TBL] [Abstract][Full Text] [Related]
32. Curcumin treatment prevents increased proteasome and apoptosome activities in rat skeletal muscle during reloading and improves subsequent recovery.
Vazeille E; Slimani L; Claustre A; Magne H; Labas R; Béchet D; Taillandier D; Dardevet D; Astruc T; Attaix D; Combaret L
J Nutr Biochem; 2012 Mar; 23(3):245-51. PubMed ID: 21497497
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.
Whitehouse AS; Tisdale MJ
Br J Cancer; 2003 Sep; 89(6):1116-22. PubMed ID: 12966435
[TBL] [Abstract][Full Text] [Related]
34. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
Chand A; Wyke SM; Tisdale MJ
Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
[TBL] [Abstract][Full Text] [Related]
35. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
Du J; Hu Z; Mitch WE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
[TBL] [Abstract][Full Text] [Related]
36. Role of the ubiquitin-proteasome pathway in sepsis-induced muscle catabolism.
Hasselgren PO
Mol Biol Rep; 1999 Apr; 26(1-2):71-6. PubMed ID: 10363650
[TBL] [Abstract][Full Text] [Related]
37. PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.
Constantin D; Constantin-Teodosiu D; Layfield R; Tsintzas K; Bennett AJ; Greenhaff PL
J Physiol; 2007 Aug; 583(Pt 1):381-90. PubMed ID: 17540700
[TBL] [Abstract][Full Text] [Related]
38. Attenuation of depression of muscle protein synthesis induced by lipopolysaccharide, tumor necrosis factor, and angiotensin II by beta-hydroxy-beta-methylbutyrate.
Eley HL; Russell ST; Tisdale MJ
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1409-16. PubMed ID: 18854427
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of skeletal muscle atrophy.
Ventadour S; Attaix D
Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
[TBL] [Abstract][Full Text] [Related]
40. Sepsis-induced muscle proteolysis is prevented by a proteasome inhibitor in vivo.
Fischer D; Gang G; Pritts T; Hasselgren PO
Biochem Biophys Res Commun; 2000 Apr; 270(1):215-21. PubMed ID: 10733930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
